GIP
ARCT icon

Granite Investment Partners’s Arcturus Therapeutics ARCT Stock Holding History

Granite Investment Partners’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2,742
Closed -$296K – 303
2014
Q3 		$296K Buy
2,742
+87
+3% +$11.3K 0.04% 263
2014
Q2 		$322K Buy
2,655
+38
+1% +$4.59K 0.05% 262
2014
Q1 		$333K Buy
+2,617
New +$388K 0.05% 213

Other funds holding ARCT

KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
LCM
Leisure Capital Management Costa Mesa, California $320M AUM 39.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Granite Investment Partners's ARCT Position: Q4 2014 in Review

Granite Investment Partners sold out of Arcturus Therapeutics (ARCT) in Q4 2014, closing a stake of 2,742 shares — an estimated $296K sold.

Granite Investment Partners first reported a position in ARCT in Q1 2014 and held it in 3 quarters. The position peaked at $333K in Q1 2014. 28 funds tracked by Wall St. Rank hold ARCT as of Q4 2014.

  • Granite Investment Partners reported no remaining Arcturus Therapeutics position as of Q4 2014 after selling out during the quarter.
  • Granite Investment Partners sold 2,742 Arcturus Therapeutics shares in Q4 2014, an estimated $296K.
  • Granite Investment Partners first reported a position in Arcturus Therapeutics in Q1 2014 and held it in 3 quarters.
  • Granite Investment Partners's Arcturus Therapeutics position peaked at $333K in Q1 2014.
  • 28 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2014.

Based on Granite Investment Partners's 13F filing for Q4 2014, filed 12 Feb 2015.